XML 51 R41.htm IDEA: XBRL DOCUMENT v3.7.0.1
Net loss per share - Schedule of Potentially Dilutive Securities Outstanding Excluded from Computations of Diluted Weighted-Average Shares Outstanding (Detail) - shares
3 Months Ended
Mar. 31, 2017
Mar. 31, 2016
Underwriter [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Antidilutive securities excluded from computations of diluted weighted-average shares outstanding 82,500 82,500
Series A Warrants to Purchase Shares of Common Stock [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Antidilutive securities excluded from computations of diluted weighted-average shares outstanding 2,425,605 2,425,605
Series C Warrant to Purchase Common Stock [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Antidilutive securities excluded from computations of diluted weighted-average shares outstanding 590,415 590,415
Series D Warrant To Purchase Common Stock [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Antidilutive securities excluded from computations of diluted weighted-average shares outstanding 2,930,812 2,810,812
Warrants Issued to 2010/2012 Convertible Note Holders to Purchase Common Stock [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Antidilutive securities excluded from computations of diluted weighted-average shares outstanding 510,350 510,350
Options to Purchase Common Stock [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Antidilutive securities excluded from computations of diluted weighted-average shares outstanding 2,934,857 2,297,639
Warrants Issued in 2009 to Purchase Common Stock [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Antidilutive securities excluded from computations of diluted weighted-average shares outstanding 9,259 9,259
Series A Convertible Preferred Stock [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Antidilutive securities excluded from computations of diluted weighted-average shares outstanding 0 4,505,405
Series B Convertible Preferred Stock [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Antidilutive securities excluded from computations of diluted weighted-average shares outstanding 12,179,000 0
Development Milestone [Member] | Essentialis, Inc. [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Effect of contingently issuable shares 913,379  
Indemnification Claims [Member] | Essentialis, Inc. [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Effect of contingently issuable shares 4,566,948